Jeevan Scientific Technology Ltd is an Independent Clinical Contract Research Organization which offers technology-driven clinical research solutionsServices Offered: a) Clinical Trial Services: Patient PK trials, Pharmacodynamic endpoint studies, Early & late phase clinical trials, Post-marketing surveillance studies, Investigator initiated and real-world evidence studies, Clinical Trials Support for Complex…
Jeevan Scientific Technology has announced its 28th Annual General Meeting (AGM) will be held on September 25, 2026, at 10:00 a.m. via video conference. Shareholders can vote electronically from September 22 to September 24, 2026, with September 18, 2026, as the cut-off date for eligibility. The company's share transfer books...
28th Annual General meeting of the Company is scheduled to be held on 25.09.2026 at 10:00 a.m.
Jeevan Scientific Technology Limited secured approval from the Central Drugs Standard Control Organization (CDSCO) for an expanded bed capacity at its Hyderabad Bioavailability/Bioequivalence (BA/BE) Study Centre. Total beds will increase from 132 to 156, and ICU beds from 6 to 8. This expansion, approved after a successful regulatory inspection, significantly...
Jeevan Scientific Technology Limited announced the successful completion of a USFDA inspection at its Bioanalytical Facility in Hyderabad. The inspection, which reviewed studies, operations, and procedures, concluded with zero observations. Inspectors noted the team's strong training, knowledge, and experience with international good practices. This positive outcome highlights JSTL's robust regulatory...
